Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Human Cancer Biology

Activation of β-Catenin by Hypoxia in Hepatocellular Carcinoma Contributes to Enhanced Metastatic Potential and Poor Prognosis

Liang Liu, Xiao-Dong Zhu, Wen-Quan Wang, Yuan Shen, Yi Qin, Zheng-Gang Ren, Hui-Chuan Sun and Zhao-You Tang
Liang Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiao-Dong Zhu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wen-Quan Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuan Shen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yi Qin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zheng-Gang Ren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hui-Chuan Sun
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhao-You Tang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-09-2610 Published May 2010
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Expression of HIF-1α and β-catenin in hypoxic HCC cell lines and HAL-treated xenografts. Immunoblotting showed that hypoxia increased β-catenin protein levels in PLC/PRF/5 and HepG2 cells (A), and induced its intracellular translocation in Hep3B and MHCC97 cells (B). The induction of HIF-1α expression by hypoxia was detected in all cells with respect to their normoxic controls. Blots were normalized to β-actin protein in each lane. The ratios of each protein relative to matched normoxic cells are listed below each blot. C, immunoblotting of tumor tissues showed that HAL markedly increased HIF-1α expression in MHCC97-R and Hep3B-R xenografts compared with those in sham-operated groups but slightly upregulated β-catenin protein level. Ratios relative to corresponding sham-operated control were normalized to β-actin. D, immunostaining revealed that most β-catenin–positive cells in above tumor tissues showed a cytoplasmic/nuclear accumulation.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Effect of hypoxia on the transcription and stabilization of β-catenin in HCC cells. A, qRT-PCR showed that hypoxia did not significantly increase β-catenin mRNA levels in HCC cells, except in HepG2 cells. B, immunoblotting revealed that the effects of hypoxia on elevated levels of β-catenin in PLC/PRF/5 and HepG2 cells, and on nuclear accumulation of β-catenin in Hep3B and MHCC97 cells, were similar to the effects of the proteasome inhibitor MG132 on β-catenin in these cells. The ratios of each protein relative to nontreated cells were normalized to β-actin. C, alterations of β-catenin in hypoxic HCC cells coincided with p-Akt expression, assayed by immunoblotting, which both were inversely related to changes in GSK-3β levels. The ratios of each protein relative to normoxic cells were normalized to β-actin. D, immunoblotting showed that LY294002 remarkably repressed hypoxia-induced GSK-3β degradation and augmentation of p-Akt. The ratios of each protein relative to normoxic cells were normalized to β-actin.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Effect of silencing β-catenin on the invasion and metastasis of MHCC97 and Hep3B cells under normoxic and hypoxic conditions. A, in vitro Transwell analysis revealed that depletion of β-catenin completely inhibited hypoxia-enhanced invasiveness of MHCC97 and Hep3B cells, and partially impaired their original invasiveness in normoxia. B, quantification of bioluminescence showed that HAL accelerated pulmonary metastasis in MHCC97-R xenografts and increased peritoneal seeding in Hep3B-R xenografts, compared with matched controls. However, the enhanced metastatic potential was abrogated significantly by silencing β-catenin. C, representative bioluminescence images visualized tumor metastatic loci in lung and peritoneum.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Effect of β-catenin knockdown on hypoxia-induced molecular changes consistent with EMT in HCC cells. A, qRT-PCR revealed an augmentation of transcription factors Snail, Slug, and Twist expression in hypoxic MHCC97 and Hep3B cells with respect to normoxic controls. When β-catenin in these cells was knocked down by shRNA, the upregulation of Slug or Twist due to hypoxia were inhibited, whereas the level of Snail mRNA was higher than that in parental cells. B, morphologic changes consistent with EMT (spindle-shaped cells with loss of polarity and increased intercellular separation) were observed in MHCC97 and Hep3B cells in response to hypoxia. C, immunoblotting showed that hypoxia-elicited EMT in MHCC97-Mock and Hep3B-Mock cells, characterized by the loss of E-cadherin and plakoglobin as well as the upregulation of vimentin and N-cadherin, was repressed by silencing β-catenin. The ratios of each protein relative to corresponding vector-transfected cells in normoxia were normalized to β-actin. D, gelatin zymography showed that hypoxia increased the expression of MMP-2 in HCC cells, which was reversed by silencing β-catenin. The activity of MMP-9 was not affected. Ratios relative to vector-transfected cells in normoxia were normalized to β-actin.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Expression patterns of HIF-1α and β-catenin immunostaining in HCC TMAs. Representative examples of H&E staining (A), negative control staining (B), weak cytoplasmic staining (C), moderate cytoplasmic staining (D), and strong nuclear staining (E) for HIF-1α; constitutive expression of β-catenin in normal bile ducts as positive control (F); weak membranous staining (G), strong membranous staining (H), cytoplasmic staining (I), and nuclear staining (J) for β-catenin in cancer tissues.

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Prognostic significance assessed by Kaplan-Meier survival estimates and log-rank tests. Comparisons of OS and TTR by HIF-1α (A and B), β-catenin (C and D), and HIF-1α/β-catenin (E and F).

Additional Files

  • Figures
  • Supplementary Data

    Files in this Data Supplement:

    • Supplementary Data
PreviousNext
Back to top
Clinical Cancer Research: 16 (10)
May 2010
Volume 16, Issue 10
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Activation of β-Catenin by Hypoxia in Hepatocellular Carcinoma Contributes to Enhanced Metastatic Potential and Poor Prognosis
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Activation of β-Catenin by Hypoxia in Hepatocellular Carcinoma Contributes to Enhanced Metastatic Potential and Poor Prognosis
Liang Liu, Xiao-Dong Zhu, Wen-Quan Wang, Yuan Shen, Yi Qin, Zheng-Gang Ren, Hui-Chuan Sun and Zhao-You Tang
Clin Cancer Res May 15 2010 (16) (10) 2740-2750; DOI: 10.1158/1078-0432.CCR-09-2610

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Activation of β-Catenin by Hypoxia in Hepatocellular Carcinoma Contributes to Enhanced Metastatic Potential and Poor Prognosis
Liang Liu, Xiao-Dong Zhu, Wen-Quan Wang, Yuan Shen, Yi Qin, Zheng-Gang Ren, Hui-Chuan Sun and Zhao-You Tang
Clin Cancer Res May 15 2010 (16) (10) 2740-2750; DOI: 10.1158/1078-0432.CCR-09-2610
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • MET in Papillary RCC
  • Identification of T-cell Antigens by Minigene Screening
  • Sirt7 Promotes Colorectal Cancer Tumorigenesis
Show more Human Cancer Biology
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement